Guidelines for clinical evaluation of chronic kidney diseaseAMED research on regulatory science of pharmaceuticals and medical devices

被引：0
|
作者：
Eiichiro Kanda
Naoki Kashihara
Kunihiro Matsushita
Tomoko Usui
Hirokazu Okada
Kunitoshi Iseki
Kenichi Mikami
Tetsuhiro Tanaka
Takashi Wada
Hirotaka Watada
Kohjiro Ueki
Masaomi Nangaku
机构：
[1] Kawasaki Medical School,Medical Science
[2] Kawasaki Medical School,Department of Nephrology and Hypertension
[3] Johns Hopkins Bloomberg School of Public Health,Department of Epidemiology
[4] Kyoto University,Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health
[5] Saitama Medical University,Department of Nephrology
[6] Tomishiro Central Hospital,Clinical Research Support Center
[7] Pharmaceuticals and Medical Devices Agency (PMDA),Office of New Drug I
[8] The University of Tokyo,Division of Nephrology and Endocrinology, Graduate School of Medicine
[9] Kanazawa University,Department of Nephrology and Laboratory Medicine
[10] Juntendo University Graduate School of Medicine,Department of Metabolism and Endocrinology
[11] Diabetes Research Center,undefined
[12] National Center for Global Health and Medicine,undefined
来源：
Clinical and Experimental Nephrology | 2018年 / 22卷
关键词：
Surrogate endpoint; Glomerular filtration rate; End-stage renal disease; Dialysis; Chronic kidney disease; Proteinuria; Guideline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1446 / 1475
页数：29
相关论文
共 50 条
  • [1] Guidelines for clinical evaluation of chronic kidney disease: AMED research on regulatory science of pharmaceuticals and medical devices
    Kanda, Eiichiro
    Kashihara, Naoki
    Matsushita, Kunihiro
    Usui, Tomoko
    Okada, Hirokazu
    Iseki, Kunitoshi
    Mikami, Kenichi
    Tanaka, Tetsuhiro
    Wada, Takashi
    Watada, Hirotaka
    Ueki, Kohjiro
    Nangaku, Masaomi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1446 - 1475
  • [2] Regulatory Science in Practice (Pharmaceuticals and Medical Devices Agency)
    Hojo, Taisuke
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (04): : 439 - 442
  • [3] The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan
    Asahina, Yasuko
    Tanaka, Ayumi
    Uyama, Yoshiaki
    Kuramochi, Kenji
    Maruyama, Hiroshi
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 19 - 22
  • [4] The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan
    Yasuko Asahina
    Ayumi Tanaka
    Yoshiaki Uyama
    Kenji Kuramochi
    Hiroshi Maruyama
    [J]. Therapeutic Innovation & Regulatory Science, 2013, 47 : 19 - 22
  • [5] Future Vision of Regulatory Science in the Global Development of Pharmaceuticals and Medical Devices
    Nakamura, Mitsuhiro
    Ikeda, Koji
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 523 - 525
  • [6] MEDICAL DEVICES AND PHARMACEUTICALS: DIFFERENCES AND REGULATORY APPROACH
    Calis, Sema
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 12 - 13
  • [7] REGULATORY SCIENCE Trust and transparency in clinical trials of medical devices
    Kramer, Daniel B.
    Cutlip, Donald E.
    [J]. NATURE REVIEWS CARDIOLOGY, 2015, 12 (09) : 503 - 504
  • [8] What is regulatory science for medical devices?
    Yamane, Takashi
    [J]. JAPANESE JOURNAL OF ARTIFICIAL ORGANS, 2019, 48 (01): : 52 - 55
  • [9] Regulatory guidelines for medical devices in India: An overview
    Radhadevi, Nadimpalli
    Balamuralidhara, Veeranna
    Kumar, Teggina Math Pramod
    Ravi, Valluru
    [J]. ASIAN JOURNAL OF PHARMACEUTICS, 2012, 6 (01) : 10 - 17
  • [10] Utilization of clinical research data other than conventional clinical trials for pharmaceuticals and medical devices
    Yamamoto, Haruko
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1350 - S1350
12345